IL22 and inflammatory bowel disease: Studies have found IL-22 can promote IBD development and tumorigenesis in mouse models if IL-22 is not properly controlled [22, 23], implying that IL-22 signaling should be correctively regulated to facilitate the maintenance of IEC integrity.